Bessemer Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9K Hold
85
– – ﹤0.01% 2189
2026
Q2
$9K Hold
85
– – ﹤0.01% 2177
2026
Q1
$9K Buy
+85
New +$9.06K ﹤0.01% 2146

Other funds holding PPH

Bessemer Group's PPH Position: Q3 2026 in Review

Bessemer Group held its VanEck Pharmaceutical ETF (PPH) position steady in Q3 2026 at 85 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #2189.

Bessemer Group first reported a position in PPH in Q1 2026 and has held it in 3 quarters since. 155 funds tracked by Wall St. Rank hold PPH as of Q3 2026.

  • Bessemer Group held 85 shares of VanEck Pharmaceutical ETF worth $9K as of Q3 2026.
  • Bessemer Group left its VanEck Pharmaceutical ETF share count unchanged in Q3 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #2189 holding.
  • Bessemer Group first reported a position in VanEck Pharmaceutical ETF in Q1 2026 and has held it in 3 quarters since.
  • 155 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.